PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-52.47%
Both yoy net incomes decline, with VET at -63.39%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.52%
Negative yoy D&A while VET is 1.33%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-35.39%
Negative yoy deferred tax while VET stands at 129.54%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
102.54%
Well above VET's 124.87% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
102.54%
Growth well above VET's 124.87%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-104.47%
Negative yoy while VET is 526.12%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
2.05%
Operating cash flow growth below 50% of VET's 54.79%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
16.35%
CapEx growth well above VET's 2.76%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.21%
Growth well above VET's 81.80%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
50.84%
Investing outflow well above VET's 62.17%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-62.65%
We cut debt repayment yoy while VET is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-0.41%
Negative yoy issuance while VET is 776.86%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-38.03%
We cut yoy buybacks while VET is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.